Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective study

The development of systemic chemotherapy including immune checkpoint inhibitors (ICIs) has provided patients with unresectable advanced non-small cell lung cancer (NSCLC) an opportunity to undergo surgical int…  Read More